The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome

NCT00759291 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DRUG: acipimox
DRUG: Placebo

Sponsor

Brigham and Women's Hospital